基础医学与临床 ›› 2017, Vol. 37 ›› Issue (4): 557-560.

• 短篇综述 • 上一篇    下一篇

单核细胞/高密度脂蛋白比值在冠心病诊断和预测预后的研究进展

黄朝发,韦怡春,李菊香   

  1. 南昌大学第二附属医院
  • 收稿日期:2016-07-04 修回日期:2016-11-24 出版日期:2017-04-05 发布日期:2017-03-24
  • 通讯作者: 李菊香 E-mail:ljx912@126.com
  • 基金资助:
    高同型半胱氨酸诱导心房肌细胞电重构的作用和机制

Research advances on the ratio of monocyte to HDL in the diagnosis and prognosis of coronary heart disease

Chao-Fa HUANG1, Ju-xiang LI   

  • Received:2016-07-04 Revised:2016-11-24 Online:2017-04-05 Published:2017-03-24
  • Contact: Ju-xiang LI, E-mail:ljx912@126.com

摘要: 绝大部分冠心病为冠状动脉粥样硬化所致,目前认为,动脉粥样硬化是一种慢性炎性反应疾病。单核细胞和高密度脂蛋白比值(MHR)是近年新兴的一种炎性反应标记物,其获取简单,检测价格低廉,与冠心病短期和长期的心血管事件发生率及死亡率相关,可作为冠心病预后的预测因素。

关键词: 单核细胞/高密度脂蛋白, 冠心病, 炎性反应标记物, 动脉粥样硬化

Abstract: Atherosclerosis is the main cause of coronary heart disease, Now it is thought that atherosclerosis is a chronic inflammatory disease. The ratio of Monocytes to high-density lipoprotein (MHR) is a new inflammatory marker of coronary atherosclerosis, which is measured simply and cheaply. MHR is associated with short-term and long-term occurrence of cardiovascular events and morbidity of Coronary heart disease, which can be used as predictor of coronary heart disease prognosis.

Key words: ratio of monocyte to HDL, coronary heart disease, inflammatory marker, atherosclerosis

中图分类号: